SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-042517
Filing Date
2023-11-22
Accepted
2023-11-22 16:45:33
Documents
13
Period of Report
2023-11-16
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47471
  Complete submission text file 0001493152-23-042517.txt   275316

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE vhaq-20231116.xsd EX-101.SCH 3709
3 XBRL DEFINITION FILE vhaq-20231116_def.xml EX-101.DEF 27241
4 XBRL LABEL FILE vhaq-20231116_lab.xml EX-101.LAB 37383
5 XBRL PRESENTATION FILE vhaq-20231116_pre.xml EX-101.PRE 25857
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6571
Mailing Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326
Business Address 3480 PEACHTREE ROAD NE 2ND FLOOR - SUITE #112 ATLANTA GA 30326 4045797978
Viveon Health Acquisition Corp. (Filer) CIK: 0001823857 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39827 | Film No.: 231434068
SIC: 2834 Pharmaceutical Preparations